MIRA Pharmaceuticals (MIRA)

• Market cap: $27.9M
• 1 day: -6.29%
• 5 days: -6.29%
• 1 month: 3.88%
• 3 months: -10.07%
• 6 months: 13.56%
• Year to date: 16.52%
• 1 year: -14.1%
• 5 years: -81.94%
• 10 years: -81.94%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Employees: 5